SHARE-BASED COMPENSATION AND WARRANTS (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Equity [Abstract] | ||
| Warrants outstanding, beginning balance | 400,000 | 200,000 |
| Weighted average exercise price, beginning balance | $ 4.00 | $ 3.00 |
| Warrants issued | 200,000 | |
| Weighted average exercise price, issued | $ 5.00 | |
| Warrants exercised | ||
| Weighted average exercise price, exercised | ||
| Warrants expired | ||
| Weighted average exercise price, expired | ||
| Warrants outstanding, ending balance | 400,000 | 400,000 |
| Weighted average exercise price, ending balance | $ 4.00 | $ 4.00 |
| Warrants exercisable | 400,000 | 400,000 |
| Weighted average exercise price, Warrants exercisable | $ 4.00 | $ 4.00 |
| X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options forfeited in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|